The Role and Applications of Exosomes in Gynecological Cancer: A Review

Exosomes are phospholipid bilayer vesicles that are released by all types of cells, containing proteins, lipids, and nucleic acids such as DNAs and RNAs. Exosomes can be transferred between cells and play a variety of physiological and pathological regulatory functions. Noncoding RNAs, including micro RNAs, long noncoding RNAs, and circular RNAs, are the most studied biomolecules from exosomes and more and more studies found that noncoding RNAs play an important role in the diagnosis, prognosis, and treatment of diseases, including various types of cancer. Gynecological malignancies such as ovarian, endometrial, and cervical cancer seriously threaten women's life. Therefore, this article reviews the roles and applications of exosomes in gynecological malignancies, including the promotion or inhibition of tumor progression and regulation of tumor microenvironments, and as potential therapeutic targets for treating gynecological cancers.

[1]  Caixia Shi,et al.  LRRC75A‐AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression , 2023, Cancer science.

[2]  Wei Chen,et al.  tRF-20-S998LO9D inhibits endometrial carcinoma by upregulating SESN2. , 2023, Epigenomics.

[3]  Genlin Li,et al.  Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells , 2023, Journal of oncology.

[4]  Zongji Shen,et al.  PDHB-AS suppresses cervical cancer progression and cisplatin resistance via inhibition on Wnt/β-catenin pathway , 2023, Cell Death & Disease.

[5]  Ting Guo,et al.  NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions , 2023, Frontiers in Immunology.

[6]  Jing Cai,et al.  Omental cancer‐associated fibroblast‐derived exosomes with low microRNA‐29c‐3p promote ovarian cancer peritoneal metastasis , 2023, Cancer science.

[7]  M. K. Siu,et al.  Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis , 2023, Molecular Cancer.

[8]  X. Ren,et al.  Exosome-transmitted circIFNGR2 Modulates Ovarian Cancer Metastasis via miR-378/ST5 Axis , 2023, Molecular and cellular biology.

[9]  Xianrang Song,et al.  Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer , 2022, Frontiers in Oncology.

[10]  Jing Cai,et al.  Tumour-derived exosomal piR-25783 promotes omental metastasis of ovarian carcinoma by inducing the fibroblast to myofibroblast transition , 2022, Oncogene.

[11]  Rui-yu Wang,et al.  Exosomal circNFIX promotes angiogenesis in ovarian cancer via miR‐518a‐3p/TRIM44 axis , 2022, The Kaohsiung journal of medical sciences.

[12]  L. Mincheva-Nilsson,et al.  NKG2D‐mediated cytotoxicity improves after primary surgery for high‐grade serous ovarian cancer , 2022, American journal of reproductive immunology.

[13]  O. Cevik,et al.  Wharton jelly-derived mesenchymal stem cell exosomes induce apoptosis and suppress EMT signaling in cervical cancer cells as an effective drug carrier system of paclitaxel , 2022, PloS one.

[14]  Jinlong Chen,et al.  Plasma exosomal miR-1260a, miR-7977 and miR-192-5p as diagnostic biomarkers in epithelial ovarian cancer. , 2022, Future oncology.

[15]  Xiaoying Wang,et al.  miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance , 2022, Journal of translational medicine.

[16]  Yoshihito Yokoyama,et al.  Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study , 2022, Molecules.

[17]  Yudong Wang,et al.  Loss of exosomal miR‐26a‐5p contributes to endometrial cancer lymphangiogenesis and lymphatic metastasis , 2022, Clinical and translational medicine.

[18]  Wei Zhao,et al.  Engineered Exosomes-Mediated Transfer of hsa-miR-320a Overcomes Chemoresistance in Cervical Cancer Cells via Targeting MCL1 , 2022, Frontiers in Pharmacology.

[19]  Xin Yan,et al.  Exosomal MiR-423-3p inhibits macrophage M2 polarization to suppress the malignant progression of cervical cancer. , 2022, Pathology, research and practice.

[20]  F. Fang,et al.  Exosome-Mediated Transfer of miR-1323 from Cancer-Associated Fibroblasts Confers Radioresistance of C33A Cells by Targeting PABPN1 and Activating Wnt/β-Catenin Signaling Pathway in Cervical Cancer , 2022, Reproductive Sciences.

[21]  Xiao Yang,et al.  Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging , 2022, Journal of Ovarian Research.

[22]  A. Aplin,et al.  Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway , 2022, Journal of experimental & clinical cancer research : CR.

[23]  Ke Gong,et al.  Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer , 2022, Journal of Nanobiotechnology.

[24]  Jue Wang,et al.  Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer , 2022, Reproductive Sciences.

[25]  Rina Su,et al.  MiR-192-5p-Modified Tumor-Associated Macrophages-Derived Exosome Suppressed Endometrial Cancer Progression Through Targeting IRAK1/NF-κB Signaling , 2022, Reproductive Sciences.

[26]  Hong Zhang,et al.  Human umbilical cord blood mesenchymal stem cells-derived exosomal microRNA-503-3p inhibits progression of human endometrial cancer cells through downregulating MEST , 2022, Cancer Gene Therapy.

[27]  Jae Hoon Kim,et al.  Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer , 2022, Current issues in molecular biology.

[28]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[29]  W. Wang,et al.  Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  Yan Gao,et al.  Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization. , 2022, Cancer letters.

[31]  Jinhong Chen,et al.  Molecular mechanism of CD163+ tumor-associated macrophage (TAM)-derived exosome-induced cisplatin resistance in ovarian cancer ascites , 2022, Annals of translational medicine.

[32]  Ying Wang,et al.  Cervical cancer-derived exosomal miR-663b promotes angiogenesis by inhibiting vinculin expression in vascular endothelial cells , 2021, Cancer cell international.

[33]  A. Botezatu,et al.  Epigenetic approaches for cervical neoplasia screening (Review) , 2021, Experimental and therapeutic medicine.

[34]  Yongjing Lai,et al.  Exosome long non-coding RNA SOX2-OT contributes to ovarian cancer malignant progression by miR-181b-5p/SCD1 signaling , 2021, Aging.

[35]  Chunhua Lu,et al.  Circular RNA Foxo3 enhances progression of ovarian carcinoma cells , 2021, Aging.

[36]  Zheyan Liu,et al.  Exosomal transfer of tumor-associated macrophage-derived hsa_circ_0001610 reduces radiosensitivity in endometrial cancer , 2021, Cell Death & Disease.

[37]  Xiaomei Liu,et al.  Exosomal miR‐21‐5p derived from cisplatin‐resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1 , 2021, Cell biology international.

[38]  Qin Luo,et al.  Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway , 2021, Neoplasia.

[39]  Fen Fu,et al.  MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer , 2021, Journal of Ovarian Research.

[40]  M. Ji,et al.  Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis , 2021, Journal of translational medicine.

[41]  Lili Lu,et al.  TAM-derived extracellular vesicles containing microRNA-29a-3p explain the deterioration of ovarian cancer , 2021, Molecular therapy. Nucleic acids.

[42]  Hui Wang,et al.  Potential of peptide‐engineered exosomes with overexpressed miR‐92b‐3p in anti‐angiogenic therapy of ovarian cancer , 2021, Clinical and translational medicine.

[43]  S. Hur,et al.  Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer , 2021, Journal of Ovarian Research.

[44]  Yuan Zhang,et al.  Exosomal miR-21-5p contributes to ovarian cancer progression by regulating CDK6 , 2021, Human Cell.

[45]  Liyuan Zhou,et al.  Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma , 2021, Molecular cancer.

[46]  D. Wirtz,et al.  Extracellular vesicles in immunomodulation and tumor progression , 2021, Nature Immunology.

[47]  Wen-Jie Zhou,et al.  CD45RO-CD8+ T cell-derived exosomes restrict estrogen-driven endometrial cancer development via the ERβ/miR-765/PLP2/Notch axis , 2021, Theranostics.

[48]  Qian Wang,et al.  LncRNA LINC01305 promotes cervical cancer progression through KHSRP and exosome-mediated transfer , 2021, Aging.

[49]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[50]  Ying Wang,et al.  Exosomal miR-663b exposed to TGF-β1 promotes cervical cancer metastasis and epithelial-mesenchymal transition by targeting MGAT3 , 2021, Oncology reports.

[51]  Jing Cai,et al.  Exosomes in ovarian cancer ascites promote epithelial–mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p , 2021, Cell Death & Disease.

[52]  A. Al-Hendy,et al.  Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy , 2021, International journal of molecular sciences.

[53]  J. Rich,et al.  Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs , 2021, Science Advances.

[54]  Xian Shu,et al.  Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis , 2021, Journal of Ovarian Research.

[55]  Xiangwei Ding,et al.  Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer , 2021, Technology in cancer research & treatment.

[56]  Weiying Lu,et al.  Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer , 2020, Oncology letters.

[57]  Y. Akao,et al.  The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy , 2020, Cancer biology & therapy.

[58]  C. Yuan,et al.  Endometrial Cancer Cells Promote M2-Like Macrophage Polarization by Delivering Exosomal miRNA-21 under Hypoxia Condition , 2020, Journal of immunology research.

[59]  Yanmei Zhang,et al.  Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment , 2020, Cell Death & Differentiation.

[60]  Q. Tan,et al.  Identification of core genes in the progression of endometrial cancer and cancer cell-derived exosomes by an integrative analysis , 2020, Scientific Reports.

[61]  Yanwei Luo,et al.  Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells , 2020, Journal of gynecologic oncology.

[62]  Fengyun Chen,et al.  Exosomal microRNA-146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2-mediated PI3K/Akt axis , 2020, International journal of molecular medicine.

[63]  Ju Zhang,et al.  The STAT3‐miR‐223‐TGFBR3/HMGCS1 axis modulates the progression of cervical carcinoma , 2020, Molecular oncology.

[64]  N. Zhang,et al.  Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1α/VEGFA axis. , 2020, Experimental cell research.

[65]  M. Sadeghizadeh,et al.  microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK/STAT3 and NF-κB signaling pathways , 2020, Journal of Cell Communication and Signaling.

[66]  Raghu Kalluri,et al.  The biology, function, and biomedical applications of exosomes , 2020, Science.

[67]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[68]  Jun-li Wang,et al.  Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis , 2019, Cancer Cell International.

[69]  Quan Chen,et al.  Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis , 2019, Theranostics.

[70]  Yaokai Chen,et al.  HIV-1-infected cell-derived exosomes promote the growth and progression of cervical cancer , 2019, International journal of biological sciences.

[71]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[72]  D. Bell,et al.  Clinical actionability of molecular targets in endometrial cancer , 2019, Nature Reviews Cancer.

[73]  Yue Li,et al.  Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression , 2019, Molecular therapy. Nucleic acids.

[74]  Michael Zhuo Wang,et al.  Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis , 2019, Cells.

[75]  Yan Lu,et al.  Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors , 2019, Molecular Cancer.

[76]  Hao Ai,et al.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Endometrial Cancer Cell Proliferation and Migration through Delivery of Exogenous miR-302a , 2019, Stem cells international.

[77]  D. Dušková,et al.  Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer , 2019, Reproductive Sciences.

[78]  K. Hua,et al.  Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer , 2018, International journal of biological sciences.

[79]  K. Pantel,et al.  Exosomal microRNAs as tumor markers in epithelial ovarian cancer , 2018, Molecular oncology.

[80]  Xinjing Wang,et al.  Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype. , 2018, Cancer letters.

[81]  Lei Huang,et al.  Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1 , 2018, Oncogene.

[82]  G. Meister,et al.  Regulation of microRNA biogenesis and its crosstalk with other cellular pathways , 2018, Nature Reviews Molecular Cell Biology.

[83]  X. Wan,et al.  Loss of exosomal miR‐148b from cancer‐associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis , 2018, Journal of cellular physiology.

[84]  R. Ramesh,et al.  A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients , 2018, The AAPS Journal.

[85]  P. Rose,et al.  Management Strategies for Recurrent Endometrial Cancer , 2018, Expert review of anticancer therapy.

[86]  A. Jemal,et al.  Ovarian cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[87]  D. Tatomer,et al.  A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs , 2018, Genes & development.

[88]  Hanzi Xu,et al.  Circular RNA expression in extracellular vesicles isolated from serum of patients with endometrial cancer. , 2018, Epigenomics.

[89]  K. Haritha,et al.  Horizontal transfer of miR-106a/b from cisplatin resistant hepatocarcinoma cells can alter the sensitivity of cervical cancer cells to cisplatin. , 2017, Cellular signalling.

[90]  Dong Li,et al.  TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA. , 2017, Cancer letters.

[91]  K. Selvendiran,et al.  The biological significance and clinical applications of exosomes in ovarian cancer. , 2016, Gynecologic oncology.

[92]  M. Guan,et al.  Exosomal Long Noncoding RNAs are Differentially Expressed in the Cervicovaginal Lavage Samples of Cervical Cancer Patients , 2016, Journal of clinical laboratory analysis.

[93]  Farooq Rashid,et al.  Long Non-coding RNAs in the Cytoplasm , 2016, Genom. Proteom. Bioinform..

[94]  Yong Li,et al.  Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1 , 2016, Nature Communications.

[95]  Clotilde Théry,et al.  Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.

[96]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[97]  D. Bartel,et al.  Expanded identification and characterization of mammalian circular RNAs , 2014, Genome Biology.

[98]  N. Matsumura,et al.  Recent Concepts of Ovarian Carcinogenesis: Type I and Type II , 2014, BioMed research international.

[99]  Qun Yu,et al.  Increased Exosomal MicroRNA-21 and MicroRNA-146a Levels in the Cervicovaginal Lavage Specimens of Patients with Cervical Cancer , 2014, International journal of molecular sciences.

[100]  V. Bajic,et al.  On the classification of long non-coding RNAs , 2013, RNA biology.

[101]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[102]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[103]  Y. Qiao,et al.  Asia Oceania Guidelines for the Implementation of Programs for Cervical Cancer Prevention and Control , 2011, Journal of cancer epidemiology.

[104]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[105]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[106]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[107]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[108]  J. Mattick,et al.  Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. , 2005, Genome research.

[109]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[110]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[111]  G. Ruvkun,et al.  Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.

[112]  P. Wolf.  The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[113]  Yuhong Wang,et al.  Exosomal miRNA-93 and miRNA-205 expression in endometrial cancer , 2020 .